When Quality of Life Is Especially Dear
Senior program officer, Amy Berman, weighs in on the public debate regaring the cancer medication, Avastin, in Wall Street Journal letter to the editor.
Senior program officer, Amy Berman, weighs in on the public debate regaring the cancer medication, Avastin, in Wall Street Journal letter to the editor. Click here to read the letter.
